Fundraising Fox

Inventia

5 known investors

Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery. The platform offers flexible discovery workflows and predefined validated solutions for teams conducting biological research and assay development.

AI & Machine LearningBiotechDeep TechMedical Devices

Investors · 5

Main Sequence VenturesSydney
Tenmile
VU Venture PartnersSan Francisco · $200K – $1M
Blackbird Venturesreported · 2 sourcesSydney · $149K – $60M
Skip Capitalreported · 2 sourcesSydney

In the news

Inventia Life Science raises $25M, launches 'RASTRUM' 3D bioprinting technology in the U.S. - 3D Printing Industry3dprintingindustry.com · Dec 2021Inventia Life Science Accelerates Growth with $25M Series B and Launches 3D Cell Culture Platform into US Marketbusinesswire.com · Dec 2021Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US - BioSpacebiospace.com · Dec 2021Biomedical research venture Inventia Life Science raises $35 million series B - Startup Dailystartupdaily.net · Dec 2021Inventia Life Science Raises $25M in Series B Fundingfinsmes.com · Dec 2021Inventia Raises €750K in Funding - FinSMEsfinsmes.com · Apr 2015

Frequently asked questions

What does Inventia do?
Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery. The platform offers flexible discovery workflows and predefined validated solutions for teams conducting biological research and assay development.
Who are Inventia's investors?
Inventia's investors include Main Sequence Ventures, Tenmile, VU Venture Partners, Blackbird Ventures, Skip Capital.